Jay S. Stout's most recent trade in Immunovant Inc was a trade of 1,925 Common Stock done at an average price of $14.8 . Disclosure was reported to the exchange on April 23, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Immunovant Inc | Jay S. Stout | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 14.79 per share. | 23 Apr 2025 | 1,925 | 209,243 (0%) | 0% | 14.8 | 28,471 | Common Stock |
| Immunovant Inc | Jay S. Stout | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 12.99 per share. | 09 Apr 2025 | 5,004 | 211,168 (0%) | 0% | 13.0 | 65,002 | Common Stock |
| Immunovant Inc | Jay S. Stout | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2025 | 107,297 | 107,297 | - | - | Stock Option (right to buy) | |
| Immunovant Inc | Jay S. Stout | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2025 | 76,181 | 216,172 (0%) | 0% | 0 | Common Stock | |
| Immunovant Inc | Jay S. Stout | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 23.59 per share. | 22 Jan 2025 | 2,195 | 139,991 (0%) | 0% | 23.6 | 51,780 | Common Stock |
| Immunovant Inc | Jay S. Stout | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 29.53 per share. | 23 Oct 2024 | 2,740 | 142,186 (0%) | 0% | 29.5 | 80,912 | Common Stock |
| Immunovant Inc | Jay S. Stout | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 27.76 per share. | 24 Jul 2024 | 2,813 | 144,926 (0%) | 0% | 27.8 | 78,089 | Common Stock |
| Immunovant Inc | Jay S. Stout | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 28.90 per share. | 24 Apr 2024 | 7,239 | 147,739 (0%) | 0% | 28.9 | 209,207 | Common Stock |
| Immunovant Inc | Jay S. Stout | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Apr 2024 | 68,723 | 68,723 | - | - | Stock Option (right to buy) | |
| Immunovant Inc | Jay S. Stout | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Apr 2024 | 54,978 | 154,978 (0%) | 0% | 0 | Common Stock | |
| Immunovant Inc | Jay S. Stout | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2023 | 150,000 | 150,000 | - | - | Stock Option (right to buy) | |
| Immunovant Inc | Jay S. Stout | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2023 | 100,000 | 100,000 (0%) | 0% | 0 | Common Stock |